MedWatch

CHMP recommends Moderna covid-19 vaccine for approval in 12-17-year-olds

From now on, children aged between 12-17 may receive the Moderna vaccine against covid-119, according to the EU CHMP. The Danish Health Authority is taking note.

Photo: JUAN MEDINA/REUTERS / X01625

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has approved the use of Moderna’s covid-19 vaccine Spikevax on children aged 12-17, according to an EMA press release

The committee has approved the vaccine following studies involving 3,732 children in this age group, which showed that its efficacy and side effects much resembled those seen in adults who have received the vaccine. 

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs